TrialClinical breast cancer2011

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Rachel A Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.